Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase III Study of Conventional Versus Hypofractionated Radiotherapy Combined With Temozolomide in Elderly Glioblastoma Patients

NCT05439278 is registered in ClinicalTrials.gov with Severance Hospital as lead sponsor.

NCT NCT05439278
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05439278 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase III Study of Conventional Versus Hypofractionated Radiotherapy Combined With Temozolomide in Elderly Glioblastoma Patients
Lead sponsor
Severance Hospital
Phase
Phase 3
Overall status
Recruiting
Start date
February 1, 2025
Completion date
December 31, 2030
Enrollment
178 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma